Evidence map›Paper›PMID 33950291›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2021

Non-coding RNAs in Wilms' tumor: biological function, mechanism, and clinical implications.

Bruna Maria de Sá Pereira, Rafaela Montalvão de Azevedo, João Victor da Silva Guerra, Paulo A Faria, Sheila Coelho Soares-Lima, Beatriz De Camargo, Mariana Maschietto

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Bruna Maria de Sá PereiraBrazilian National Cancer Institute (INCa), Rio de Janeiro, RJ, Brazil.ORCID 0000-0001-9544-7283
Rafaela Montalvão de AzevedoBrazilian National Cancer Institute (INCa), Rio de Janeiro, RJ, Brazil.ORCID 0000-0002-3868-7894
João Victor da Silva GuerraBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP, Brazil.ORCID 0000-0002-6800-4425
Paulo A FariaBrazilian National Cancer Institute (INCa), Rio de Janeiro, RJ, Brazil.ORCID 0000-0003-1817-4888
Sheila Coelho Soares-LimaBrazilian National Cancer Institute (INCa), Rio de Janeiro, RJ, Brazil.ORCID 0000-0002-6742-3708
Beatriz De CamargoBrazilian National Cancer Institute (INCa), Rio de Janeiro, RJ, Brazil.ORCID 0000-0002-5794-1042
Mariana MaschiettoBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP, Brazil. marianamasc@gmail.com.ORCID 0000-0003-2589-3186
Instituto Nacional de Câncer - INCA · BRCentro Infantil Boldrini · BRUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-coding RNAs are involved with maintenance and regulation of physiological mechanisms and are involved in pathological processes, such as cancer. Among the small ncRNAs, miRNAs are the most explored in tumorigenesis, metastasis development, and resistance to chemotherapy. These small molecules of ~ 22 nucleotides are modulated during early renal development, involved in the regulation of gene expression and Wilms' tumor progression. Wilms' tumors are embryonic tumors with few mutations and complex epigenetic dysregulation. In recent years, the small ncRNAs have been explored as potentially related both in physiological development and in the tumorigenesis of several types of cancer. Besides, genes regulated by miRNAs are related to biological pathways as PI3K, Wnt, TGF-β, and Hippo signaling pathways, among others, which may be involved with the underlying mechanisms of resistance to chemotherapy, and in this way, it has emerged as potential targets for cancer therapies, including for Wilms' tumors.

Indexed as

Biomarkers, TumorGene Expression Regulation, NeoplasticDisease SusceptibilityDrug Resistance, NeoplasmGenetic Predisposition to DiseaseHumansMicroRNAsRNA InterferenceRNA, MessengerRNA, UntranslatedSignal TransductionWilms TumorBiomarkers, TumorMicroRNAsRNA, MessengerRNA, UntranslatedCell signaling pathwaysGene expression regulationMicroRNAsSmall non-coding RNAsWilms’ tumor

Identifiers

PMID33950291
OpenAlexW3158314120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.